{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T19:14:21Z","timestamp":1795288461593,"version":"4.10.3"},"reference-count":48,"publisher":"Oxford University Press (OUP)","funder":[{"name":"the Intramural Research Program and the Cancer Cures \u201cMoonshot\u201d Initiative of the US National Institutes of Health","id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"US Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The cost-effectiveness of cervical cancer screening strategies is estimated by health decision models. Fidelity to human papillomavirus (HPV) natural history and multistate carcinogenesis is critical to improve evaluations of new screening tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed a new health decision model of the HPV genotype-specific causal pathway to cervical cancer based on cohort, trial, and cross-sectional data. The novel model presents several new approaches in representing early HPV natural history: (1) transitions between health states are estimated by new statistical approaches adapted to handle intermittently observed data, (2) transitions are directly estimated from observational data (ie, statistically identifiable) rather than calibrated to fit, and (3) precancer is rigorously defined using histopathology and HPV genotyping as a surrogate for cancer risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We present a model for pending policy decisions in Brazil. Model outputs closely matched age-specific prevalence data from S\u00e3o Paulo for 13 carcinogenic HPV types: 16, 18, 31, 33, 35, 45, 52, and 58 (modeled individually) and 39, 51, 56, 59, and 68 (grouped). The model-projected median age of precancer was 30.1\u2009years (95% CI = 27.9 to 32.3\u2009years).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>By restricting model health states and transitions to the essential, directly observable causal pathway, our approach can generate metrics with measurable SEs for cost-effectiveness analyses. Comparative modeling analyses are underway to assess differences in results relative to existing state-of-the-art models. Our approach can be generalized to evaluate the cost-effectiveness of an HPV-based screen-triage-treat approach with extended genotyping that has been demonstrated efficacious in 9 countries in the PAVE Study Consortium.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djag376","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:32:21Z","timestamp":1791286341000},"source":"Crossref","is-referenced-by-count":0,"title":["A new microsimulation model of human papillomavirus natural history for comparison of novel cervical screening strategies"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0840-4339","authenticated-orcid":false,"given":"Nicole G","family":"Campos","sequence":"first","affiliation":[{"name":"Center for Health Decision Science, Harvard T.H. Chan School of Public Health , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li C","family":"Cheung","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1162-4348","authenticated-orcid":false,"given":"Fangya","family":"Mao","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD,","place":["United States"]},{"name":"Department of Biostatistics, School of Public Health and Health Professions, University at Buffalo , Buffalo, NY,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3614-210X","authenticated-orcid":false,"given":"Brian","family":"Befano","sequence":"additional","affiliation":[{"name":"Information Management Services Inc , Calverton, MD,","place":["United States"]},{"name":"Department of Epidemiology, University of Washington , Seattle, WA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5617-4585","authenticated-orcid":false,"given":"Didem","family":"Egemen","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8090-3768","authenticated-orcid":false,"given":"Stephen","family":"Sy","sequence":"additional","affiliation":[{"name":"Center for Health Decision Science, Harvard T.H. Chan School of Public Health , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane J","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Health Decision Science, Harvard T.H. Chan School of Public Health , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1251-0836","authenticated-orcid":false,"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8992-5944","authenticated-orcid":false,"given":"Kanan","family":"Desai","sequence":"additional","affiliation":[{"name":"Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell at Norwalk Hospital , Norwalk, CT,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"de Sanjos\u00e9","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD,","place":["United States"]},{"name":"ISGlobal , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"2026112113461798700_djag376-B1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodr\u00edguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2026112113461798700_djag376-B2","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"Plummer","year":"2007","journal-title":"J Infect Dis"},{"key":"2026112113461798700_djag376-B3","doi-asserted-by":"publisher","first-page":"e075925","DOI":"10.1136\/bmj-2023-075925","article-title":"Untreated cervical intraepithelial neoplasia grade 2 and subsequent risk of cervical cancer: population based cohort study","volume":"383","author":"Dyhr Lycke","year":"2023","journal-title":"BMJ"},{"key":"2026112113461798700_djag376-B4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"2026112113461798700_djag376-B5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","article-title":"Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature","volume":"404","author":"Wei","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"2026112113461798700_djag376-B6","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1093\/jnci\/djr319","article-title":"Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16\/18 vaccine","volume":"103","author":"Kreimer","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"2026112113461798700_djag376-B7","author":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition","year":"2024"},{"key":"2026112113461798700_djag376-B8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jama.2017.19872","article-title":"Screening for cervical cancer in primary care: a decision analysis for the US preventive services task force","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA"},{"key":"2026112113461798700_djag376-B9","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1038\/s41591-023-02600-4","article-title":"Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population","volume":"29","author":"Simms","year":"2023","journal-title":"Nat Med"},{"key":"2026112113461798700_djag376-B10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jclinepi.2020.09.018","article-title":"GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making","volume":"129","author":"Brozek","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"2026112113461798700_djag376-B11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1289\/ehp.98106s61453","article-title":"Evaluation (not validation) of quantitative models","volume":"106 Suppl 6","author":"Oreskes","year":"1998","journal-title":"Environ Health Perspect"},{"key":"2026112113461798700_djag376-B12","doi-asserted-by":"publisher","first-page":"100570","DOI":"10.1016\/j.epidem.2022.100570","article-title":"Contribution and quality of mathematical modeling evidence in World Health Organization guidelines: a systematic review","volume":"39","author":"Lo","year":"2022","journal-title":"Epidemics"},{"key":"2026112113461798700_djag376-B13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/jnci\/djz227","article-title":"Estimating the natural history of cervical carcinogenesis using simulation models: a CISNET comparative analysis","volume":"112","author":"Burger","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"2026112113461798700_djag376-B14","doi-asserted-by":"publisher","first-page":"106438","DOI":"10.1016\/j.ypmed.2021.106438","article-title":"A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer","volume":"144","author":"Campos","year":"2021","journal-title":"Prev Med"},{"key":"2026112113461798700_djag376-B15","author":"National Cancer Institute Cancer Intervention and Surveillance Modeling Network (CISNET) Model Registry: HSPH-Cervical (Harvard)","year":"2025"},{"key":"2026112113461798700_djag376-B16","author":"Brisson","year":"2024"},{"key":"2026112113461798700_djag376-B17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"2026112113461798700_djag376-B18","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/AOG.0b013e318237caf4","article-title":"The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy","volume":"118","author":"Castle","year":"2011","journal-title":"Obstet Gynecol"},{"key":"2026112113461798700_djag376-B19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/0272989X18792283","article-title":"Nonidentifiability in model calibration and implications for medical decision making","volume":"38","author":"Alarid-Escudero","year":"2018","journal-title":"Med Decis Making"},{"key":"2026112113461798700_djag376-B20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/PAS.0000000000000342","article-title":"Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion?","volume":"39","author":"van der Marel","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"2026112113461798700_djag376-B21","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1016\/B0-08-043076-7\/00743-9","article-title":"Event history analysis: applications","author":"Blossfeld","journal-title":"International Encyclopedia of the Social & Behavioral Sciences"},{"key":"2026112113461798700_djag376-B22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/infdis\/jiaf574","article-title":"IPVS consensus statement on the natural history of cervical human papillomavirus infection","volume":"233","author":"Ryser","year":"2026","journal-title":"J Infect Dis"},{"key":"2026112113461798700_djag376-B23","year":"1997"},{"key":"2026112113461798700_djag376-B24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1158\/1940-6207.CAPR-19-0076","article-title":"High-risk HPV testing in primary screening for cervical cancer in the public health system, Sao Paolo, Brazil","volume":"12","author":"Levi, Jose","year":"2019","journal-title":"Cancer Prev Res (Phila Pa)"},{"key":"2026112113461798700_djag376-B25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1590\/s1020-49892004000200002","article-title":"Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica","volume":"15","author":"Bratti","year":"2004","journal-title":"Rev Panam Salud Publica"},{"key":"2026112113461798700_djag376-B26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"Solomon","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"2026112113461798700_djag376-B27","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1158\/2159-8290.CD-11-0131","article-title":"Prevention of persistent human papillomavirus infection by an HPV16\/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica","volume":"1","author":"Herrero","year":"2011","journal-title":"Cancer Discov"},{"key":"2026112113461798700_djag376-B28","doi-asserted-by":"publisher","first-page":"kxag022","DOI":"10.1093\/biostatistics\/kxag022","article-title":"Data-augmented multistate modeling for chronic disease processes using cross-sectional studies: application to HPV and cervical precancer","volume":"27","author":"Mao","year":"2026","journal-title":"Biostatistics"},{"key":"2026112113461798700_djag376-B29","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/ijc.34128","article-title":"Different human papillomavirus types share early natural history transitions in immunocompetent women","volume":"151","author":"Adebamowo","year":"2022","journal-title":"Int J Cancer"},{"key":"2026112113461798700_djag376-B30","doi-asserted-by":"publisher","first-page":"100293","DOI":"10.1016\/j.eclinm.2020.100293","article-title":"A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs","volume":"22","author":"Demarco","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2026112113461798700_djag376-B31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.virol.2005.04.002","article-title":"The carcinogenicity of human papillomavirus types reflects viral evolution","volume":"337","author":"Schiffman","year":"2005","journal-title":"Virology"},{"key":"2026112113461798700_djag376-B32","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.2517-6161.1976.tb01597.x","article-title":"The empirical distribution function with arbitrarily grouped, censored and truncated data","volume":"38","author":"Turnbull","year":"1976","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"2026112113461798700_djag376-B33","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1002\/sim.7380","article-title":"Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records","volume":"36","author":"Cheung","year":"2017","journal-title":"Stat Med"},{"key":"2026112113461798700_djag376-B34","author":"United Nations, Department of Economic and Social Affairs, Population Division","year":"2024"},{"key":"2026112113461798700_djag376-B35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/aje\/kwu159","article-title":"An updated natural history model of cervical cancer: derivation of model parameters","volume":"180","author":"Campos","year":"2014","journal-title":"Am J Epidemiol"},{"key":"2026112113461798700_djag376-B36","doi-asserted-by":"publisher","first-page":"ofae690","DOI":"10.1093\/ofid\/ofae690","article-title":"Natural history of high-risk human Papillomavirus in Kenyan and South African women: implications for vaccination campaigns and cervical cancer screening programs","volume":"11","author":"Happel","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026112113461798700_djag376-B37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/LGT.0000000000000530","article-title":"A study of partial human Papillomavirus genotyping in support of the 2019 ASCCP risk-based management consensus guidelines","volume":"24","author":"Demarco","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"2026112113461798700_djag376-B38","author":"Gargano","year":"2025"},{"key":"2026112113461798700_djag376-B39","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"key":"2026112113461798700_djag376-B40","author":"Institute for Health Metrics and Evaluation","year":"2021"},{"key":"2026112113461798700_djag376-B41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/ijgc-2021-002972","article-title":"Characteristics of patients diagnosed with cervical cancer in Brazil: preliminary results of the prospective cohort EVITA study (EVA001\/LACOG 0215)","volume":"32","author":"Rodrigues","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"2026112113461798700_djag376-B42","doi-asserted-by":"publisher","DOI":"10.36229\/978-65-5866-534-2.CAP.30","volume-title":"XIII Jornada de Inicia\u00e7\u00e3o Cient\u00edfica Da FCecon \u2013 Edi\u00e7\u00e3o 2023\/2024","author":"Silva","year":"2025","edition":"1st ed"},{"key":"2026112113461798700_djag376-B43","doi-asserted-by":"publisher","first-page":"e0187579","DOI":"10.1371\/journal.pone.0187579","article-title":"Five-year survival and associated factors in women treated for cervical cancer at a reference hospital in the Brazilian Amazon","volume":"12","author":"Carneiro","year":"2017","journal-title":"PLoS One"},{"key":"2026112113461798700_djag376-B44","doi-asserted-by":"publisher","first-page":"20761","DOI":"10.1038\/s41598-024-71735-2","article-title":"Transition from opportunistic cytological to organized screening program with DNA-HPV testing detected prevalent cervical cancers 10 years in advance","volume":"14","author":"Teixeira","year":"2024","journal-title":"Sci Rep"},{"key":"2026112113461798700_djag376-B45","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/ijc.33033","article-title":"Association of HPV35 with cervical carcinogenesis among women of African ancestry: evidence of viral-host interaction with implications for disease intervention","volume":"147","author":"Pinheiro","year":"2020","journal-title":"Int J Cancer"},{"key":"2026112113461798700_djag376-B46","doi-asserted-by":"publisher","first-page":"RP91469","DOI":"10.7554\/eLife.91469","article-title":"Design of the HPV-automated visual evaluation (PAVE) study: validating a novel cervical screening strategy","volume":"12","author":"de Sanjos\u00e9","year":"2024","journal-title":"Elife"},{"key":"2026112113461798700_djag376-B47","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1093\/jnci\/djaf054","article-title":"Initial evaluation of a new cervical screening strategy combining human papillomavirus genotyping and automated visual evaluation: the Human Papillomavirus\u2013automated visual evaluation consortium","volume":"117","author":"Befano","year":"2025","journal-title":"J Natl Cancer Inst."},{"key":"2026112113461798700_djag376-B48","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/jncimonographs\/lgae040","article-title":"A cervical cancer control strategy for lower-resource settings: interventions to complement one-dose HPV vaccination","volume":"2024","author":"Campos","year":"2024","journal-title":"J Natl Cancer Inst Monogr"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag376\/71789094\/djag376.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag376\/71789094\/djag376.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T18:46:22Z","timestamp":1795286782000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article\/doi\/10.1093\/jnci\/djag376\/8898733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":48,"URL":"https:\/\/doi.org\/10.1093\/jnci\/djag376","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"article-number":"djag376"}}